Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Sialic Acid-Containing Glycans as Cellular Receptors for Ocular Human Adenoviruses: Implications for Tropism and Treatment.

Chandra N, Frängsmyr L, Imhof S, Caraballo R, Elofsson M, Arnberg N.

Viruses. 2019 Apr 27;11(5). pii: E395. doi: 10.3390/v11050395.

2.

Corticosteroids protect infected cells against mycobacterial killing in vitro.

Tükenmez H, Edström I, Kalsum S, Braian C, Ummanni R, Fick SB, Sundin C, Lerm M, Elofsson M, Larsson C.

Biochem Biophys Res Commun. 2019 Mar 26;511(1):117-121. doi: 10.1016/j.bbrc.2019.02.044. Epub 2019 Feb 14.

3.

Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening.

Tükenmez H, Edström I, Ummanni R, Fick SB, Sundin C, Elofsson M, Larsson C.

Sci Rep. 2019 Jan 10;9(1):26. doi: 10.1038/s41598-018-37176-4.

4.

Red Fluorescent Chlamydia trachomatis Applied to Live Cell Imaging and Screening for Antibacterial Agents.

Mojica SA, Eriksson AU, Davis RA, Bahnan W, Elofsson M, Gylfe Å.

Front Microbiol. 2018 Dec 18;9:3151. doi: 10.3389/fmicb.2018.03151. eCollection 2018.

5.

Cyclopropylmethyl Protection of Phenols: Total Synthesis of the Resveratrol Dimers Anigopreissin A and Resveratrol-Piceatannol Hybrid.

Kumar A, Saleeb M, Werz D, Elofsson M.

ChemistryOpen. 2018 Nov 5;7(12):953-956. doi: 10.1002/open.201800214. eCollection 2018 Dec.

6.

PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.

Beck C, Rodriguez-Vargas JM, Boehler C, Robert I, Heyer V, Hanini N, Gauthier LR, Tissier A, Schreiber V, Elofsson M, Reina San Martin B, Dantzer F.

Cell Death Differ. 2018 Nov 15. doi: 10.1038/s41418-018-0233-1. [Epub ahead of print]

PMID:
30442946
7.

Synthesis of Indole-, Benzo[ b]thiophene-, and Benzo[ b]selenophene-Based Analogues of the Resveratrol Dimers Viniferifuran and (±)-Dehydroampelopsin B.

Krzyzanowski A, Saleeb M, Elofsson M.

Org Lett. 2018 Nov 2;20(21):6650-6654. doi: 10.1021/acs.orglett.8b02638. Epub 2018 Oct 15.

PMID:
30350667
8.

14-3-3 proteins activate Pseudomonas exotoxins-S and -T by chaperoning a hydrophobic surface.

Karlberg T, Hornyak P, Pinto AF, Milanova S, Ebrahimi M, Lindberg M, Püllen N, Nordström A, Löverli E, Caraballo R, Wong EV, Näreoja K, Thorsell AG, Elofsson M, De La Cruz EM, Björkegren C, Schüler H.

Nat Commun. 2018 Sep 17;9(1):3785. doi: 10.1038/s41467-018-06194-1.

9.

Type III secretion inhibitors for the management of bacterial plant diseases.

Puigvert M, Solé M, López-Garcia B, Coll NS, Beattie KD, Davis RA, Elofsson M, Valls M.

Mol Plant Pathol. 2019 Jan;20(1):20-32. doi: 10.1111/mpp.12736. Epub 2018 Oct 19.

PMID:
30062690
10.

Screening for Inhibitors of Acetaldehyde Dehydrogenase (AdhE) from Enterohemorrhagic Escherichia coli (EHEC).

Zetterström CE, Uusitalo P, Qian W, Hinch S, Caraballo R, Grundström C, Elofsson M.

SLAS Discov. 2018 Sep;23(8):815-822. doi: 10.1177/2472555218768062. Epub 2018 Apr 9.

PMID:
29630847
11.

Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.

Islam MK, Strand M, Saleeb M, Svensson R, Baranczewski P, Artursson P, Wadell G, Ahlm C, Elofsson M, Evander M.

Sci Rep. 2018 Jan 31;8(1):1925. doi: 10.1038/s41598-018-20362-9.

12.

Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.

Ekblad T, Verheugd P, Lindgren AE, Nyman T, Elofsson M, Schüler H.

SLAS Discov. 2018 Apr;23(4):353-362. doi: 10.1177/2472555217750870. Epub 2018 Jan 9.

PMID:
29316839
13.

Natural product inspired library synthesis - Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis.

Saleeb M, Mojica S, Eriksson AU, Andersson CD, Gylfe Å, Elofsson M.

Eur J Med Chem. 2018 Jan 1;143:1077-1089. doi: 10.1016/j.ejmech.2017.11.099. Epub 2017 Dec 5.

14.

Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.

Saleeb M, Sundin C, Aglar Ö, Pinto AF, Ebrahimi M, Forsberg Å, Schüler H, Elofsson M.

Eur J Med Chem. 2018 Jan 1;143:568-576. doi: 10.1016/j.ejmech.2017.11.036. Epub 2017 Nov 21.

15.

N-Acylated Derivatives of Sulfamethoxazole Block Chlamydia Fatty Acid Synthesis and Interact with FabF.

Mojica SA, Salin O, Bastidas RJ, Sunduru N, Hedenström M, Andersson CD, Núñez-Otero C, Engström P, Valdivia RH, Elofsson M, Gylfe Å.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00716-17. doi: 10.1128/AAC.00716-17. Print 2017 Oct.

16.

Total Synthesis of Viniferifuran, Resveratrol-Piceatannol Hybrid, Anigopreissin A and Analogues - Investigation of Demethylation Strategies.

Vo DD, Elofsson M.

Adv Synth Catal. 2016 Dec 22;358(24):4085-4092. doi: 10.1002/adsc.201601089. Epub 2016 Dec 8.

17.

The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.

Uusitalo P, Hägglund U, Rhöös E, Scherman Norberg H, Elofsson M, Sundin C.

J Antibiot (Tokyo). 2017 Aug;70(9):937-943. doi: 10.1038/ja.2017.64. Epub 2017 Jun 7.

PMID:
28588224
18.

Diversity-Oriented Synthesis of Libraries Based on Benzofuran and 2,3-Dihydrobenzofuran Scaffolds.

Qin L, Vo DD, Nakhai A, Andersson CD, Elofsson M.

ACS Comb Sci. 2017 Jun 12;19(6):370-376. doi: 10.1021/acscombsci.7b00014. Epub 2017 Mar 27.

19.

N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.

Sunduru N, Svensson M, Cipriano M, Marwaha S, Andersson CD, Svensson R, Fowler CJ, Elofsson M.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):513-521. doi: 10.1080/14756366.2016.1265520.

20.

Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity.

Pinto AF, Ebrahimi M, Saleeb M, Forsberg Å, Elofsson M, Schüler H.

J Biomol Screen. 2016 Jul;21(6):590-5. doi: 10.1177/1087057116629923. Epub 2016 Feb 5.

PMID:
26850638

Supplemental Content

Loading ...
Support Center